We are proud to be trailblazers shaping the psychedelic medicine industry in Southern California and across the world.Read, watch, and listen to content from our expert clinicians & leaders below.
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial | Nature Medicine
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study | Nature Medicine
Ketamine and depression: a review in The Ketamine Papers — Science, Therapy and Transformation | MAPS
Probable Ketamine-Induced Hypomanic-Like Episode in a Child with Cerebral Palsy | The Journal of Neuropsychiatry and Clinical Neuroscience
Psychedelic Harm Reduction Community CouncilPresented by Brooke Balliett, LMFT; Liz Willis, PMHNP; Ryan Beauregard; and Adam RubinZendo Project
MDMA-Assisted Therapy for PTSDPresented by Dr. Cole Marta, Dr. Mike Burke, and Joseph McCowan, PsyDYale Psychedelic Science Group
Future of Psychedelic Medicine in Los AngelesPresented by Dr. Cole Marta and Brooke Balliett, LMFTAware Project
Psychedelics: Pathway to LegalizationPresented by Dr. Cole Marta and Ashley BoothFuture Cannabis Project
Zendo Project: Harm Reduction at Transformational FestivalsPresented by Brooke Balliett, LMFT and Erica Siegal, LCSWAware Project